Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' STIEBER P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Holdenrieder, S; Stieber, P; Bodenmuller, H; Fertig, G; Furst, H; Schmeller, N; Untch, M; Seidel, D
      Nucleosomes in serum as a marker for cell death

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    2. Konecny, G; Untch, M; Pihan, A; Kimmig, R; Gropp, M; Stieber, P; Hepp, H; Slamon, D; Pegram, M
      Association of urokinase-type plasminogen activator and its inhibitor withdisease progression and prognosis in ovarian cancer

      CLINICAL CANCER RESEARCH
    3. Lein, M; Jung, K; Hammerer, P; Graefen, M; Semjonow, A; Stieber, P; Ossendorf, M; Luboldt, HJ; Brux, B; Stephan, C; Schnorr, D; Loening, SA
      A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis

      PROSTATE
    4. Sreejayan, N; Wittig, BM; Von Stillfried, N; Hennicke, MS; Meyer, G; Stieber, P; Lamerz, R; Von Ritter, C
      Human biliary mucin binds to E-selectin: a possible role in modulation of inflammation

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    5. Holdenrieder, S; Stieber, P; Bodenmuller, H; Busch, M; Fertig, G; Furst, H; Schalhorn, A; Schmeller, N; Untch, M; Seidel, D
      Nucleosomes in serum of patients with benign and malignant diseases. (vol 95, pg 114, 2001)

      INTERNATIONAL JOURNAL OF CANCER
    6. Holdenrieder, S; Stieber, P; Bodenmuller, H; Busch, M; Fertig, G; Furst, H; Schalhorn, A; Schmeller, N; Untch, M; Seidel, D
      Nucleosomes in serum of patients with benign and malignant diseases

      INTERNATIONAL JOURNAL OF CANCER
    7. Semjonow, A; Oberpenning, F; Weining, C; Schon, M; Brandt, B; De Angelis, G; Heinecke, A; Hamm, M; Stieber, P; Hertle, L; Schmid, HP
      Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?

      CLINICAL CHEMISTRY
    8. Stieber, P; Molina, R; Chan, DW; Fritsche, HA; Beyrau, R; Bonfrer, JMG; Filella, X; Gornet, TG; Hoff, T; Jager, W; van Kamp, GJ; Nagel, D; Peisker, K; Sokoll, LJ; Troalen, F; Untch, M; Domke, I
      Evaluation of the analytical and clinical performance of the Elecsys (R) CA 15-3 immunoassay

      CLINICAL CHEMISTRY
    9. Wichmann, MW; Muller, C; Lau-Werner, U; Strauss, T; Lang, RA; Hornung, HM; Stieber, P; Schildberg, FW
      The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer

      LANGENBECKS ARCHIVES OF SURGERY
    10. Wichmann, MW; Lau-Werner, U; Muller, C; Hornung, HM; Stieber, P; Schildberg, FW
      Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer

      ANTICANCER RESEARCH
    11. Reiter, W; Stieber, P; Reuter, C; Nagel, D; Lau-Werner, U; Lamerz, R
      Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer

      ANTICANCER RESEARCH
    12. Holubec, L; Topolcan, O; Pikner, R; Pecen, L; Vaclavickova, J; Wirthova, M; Molacek, J; Stieber, P; Holdenrieder, S; Sen, LH; Finek, J
      The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence

      ANTICANCER RESEARCH
    13. Stieber, P; Bues, MA; Grandjean, BPA
      Simple approach to characterizing a pollution event return period in urbanhydrology, by means of hydrological parameters

      HYDROLOGICAL SCIENCES JOURNAL-JOURNAL DES SCIENCES HYDROLOGIQUES
    14. Hasholzner, U; Stieber, P; Zimmermann, A; Burges, A; Hofmann, K; Schmitt, UM; Schmeller, N; Schalhorn, A
      Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases

      ANTICANCER RESEARCH
    15. Heinemann, V; Schermuly, MM; Stieber, P; Schulz, L; Jungst, D; Wilkowski, R; Schalhorn, A
      CA19-9: A pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin

      ANTICANCER RESEARCH
    16. Hasholzner, U; Stieber, P; Reiter, W; Zimmermann, A; Hofmann, K; Schalhorn, A
      CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer

      ANTICANCER RESEARCH
    17. Lamerz, R; Runge, M; Stieber, P; Meissner, E
      Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases

      ANTICANCER RESEARCH
    18. Ebeling, FC; Schmitt, UM; Untch, M; Nagel, D; Fateh-Moghadam, A; Stieber, P; Seidel, D
      Tumour markers CEA and CA 15-3 as prognostic factors in breast cancer - Univariate and multivariate analysis

      ANTICANCER RESEARCH
    19. Mahnert, B; Tauber, S; Kriegmair, M; Schmitt, UM; Hashholzner, U; Reiter, W; Hofmann, K; Schmeller, N; Stieber, P
      BTA-TRAK (TM) - A useful diagnostic tool in urinary bladder cancer?

      ANTICANCER RESEARCH
    20. Stieber, P; Zimmermann, A; Reinmiedl, J; Muller, C; Hoffmann, H; Dienemann, H
      CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC)

      ANTICANCER RESEARCH
    21. Stieber, P; Dienemann, H; Schalhorn, A; Schmitt, UM; Reinmiedl, J; Hofmann, K; Yamaguchi, K
      Pro-gastrin-releasing peptide (ProGRP) - A useful marker in small cell lung carcinomas

      ANTICANCER RESEARCH
    22. Holdenrieder, S; Stieber, P; Forg, T; Kuhl, M; Schulz, L; Busch, M; Schalhorn, A; Seidel, D
      Apoptosis in serum of patients with solid tumours

      ANTICANCER RESEARCH
    23. Stieber, P; Untch, M; Sauer, H
      Role of tumor markers in breast cancer

      GYNAKOLOGE
    24. Schmitt, UM; Stieber, P; Jungst, D; Bilzer, M; Wachtler, M; Heberger, S; Seidel, D
      Carbohydrate deficient transferrin is not a useful marker for the detection of chronic alcohol abuse

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    25. VOGESER M; REITER W; SCHMITT UM; BILZER M; STIEBER P
      EVALUATION OF THE ELECSYS-2010 AFP ASSAY

      Tumordiagnostik & Therapie
    26. RITZKE C; STIEBER P; UNTCH M; NAGEL D; EIERMANN W; FATEHMOGHADAM A
      ALKALINE-PHOSPHATASE ISOENZYMES IN DETECTION AND FOLLOW-UP OF BREAST-CANCER METASTASES

      Anticancer research
    27. SCHMITT UM; STIEBER P; JUNGST D; BILZER M; WACHTLER M; HEBERGER S; SEIDEL D
      CARBOHYDRATE-DEFICIENT TRANSFERRIN IS NOT A USEFUL MARKER FOR THE DETECTION OF CHRONIC ALCOHOL-ABUSE

      European journal of clinical investigation
    28. REITER W; STIEBER P; SCHMELLER N; NAGEL D; SCHAMBECK C; FATEHMOGHADAM A
      IS FREE PROSTATE-SPECIFIC ANTIGEN HELPFUL IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE

      Tumor biology
    29. WOLLENBERG B; VONJAN N; SAUTIER W; HOFMANN K; SCHMITT UM; STIEBER P
      SERUM LEVELS OF INTERCELLULAR-ADHESION MOLECULE-1 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Tumor biology
    30. REITER W; STIEBER P; SCHMELLER N; NAGEL D; HOFMANN K; FATEHMOGHADAM A
      TOTAL AND FREE PSA - A METHODICAL AND CLINICAL-EVALUATION OF 5 ASSAYS

      Anticancer research
    31. REITER W; STIEBER P; SCHMELLER N; NAGEL D; FATEHMOGHADAM A
      ALPHA(1)-ANTICHYMOTRYPSIN-PSA (ACT-PSA) - A USEFUL MARKER IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE

      Anticancer research
    32. REITER W; STIEBER P; REUTER C; NAGEL D; CRAMER C; PAHL H; FATEHMOGHADAM A
      PROGNOSTIC VALUE OF PREOPERATIVE SERUM LEVELS OF CEA CA-19-9 AND CA-72-4 IN GASTRIC-CARCINOMA

      Anticancer research
    33. VONRITTER C; EDER MI; STIEBER P; LAMERZ R; JUNGST D; STRIGL M; MEYER G; REUTER C; PAUMGARTNER G
      BILIARY MUCIN SECRETED BY CULTURED HUMAN GALLBLADDER EPITHELIAL-CELLSCARRIES THE EPITOPE OF CA-19-9

      Anticancer research
    34. REITER W; STIEBER P; REUTER C; NAGEL D; LAUWERNER U; PAHL H; FATEHMOGHADAM A
      PREOPERATIVE SERUM LEVELS OF CEA AND CA-19-9 AND THEIR PROGNOSTIC-SIGNIFICANCE IN COLORECTAL-CARCINOMA

      Anticancer research
    35. MEIER W; STIEBER P; HASHOLZNER U; GROPP M; FATEHMOGHADAM A
      PROGNOSTIC-SIGNIFICANCE OF CA125 IN PATIENTS WITH OVARIAN-CANCER AND SECONDARY DEBULKING SURGERY

      Anticancer research
    36. MEIER W; BAUMGARTNER L; STIEBER P; HASHOLZNER U; FATEHMOGHADAM A
      SIGNIFICANCE OF TUMOR-MARKER DETERMINATIONS IN THE PRIMARY THERAPY OFOVARIAN-CANCER

      Anticancer research
    37. MEIER W; STIEBER P; HASHOLZNER U; BAUMGARTNER L; FATEHMOGHADAM A
      PROGNOSTIC-SIGNIFICANCE OF SQUAMOUS-CELL CARCINOMA (SCC) ANTIGEN IN PRIMARY ADVANCED AND RECURRENT CERVICAL-CARCINOMA

      Anticancer research
    38. WAIDELICH R; JANSEN HM; STIEBER P; SCHMELLER N; LAMERZ R; WERDAN K; FATEHMOGHADAM A
      SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE-SPECIFIC ANTIGEN

      Anticancer research
    39. REITER W; STIEBER P; SCHMELLER N; NAGEL D; JANSEN HM; SCHAMBECK C; FABRICIUS PG; PAHL H; MATTES M; CONSTABEL H; FATEHMOGHADAM A
      THE RATIO OF FREE TO TOTAL PROSTATE-SPECIFIC ANTIGEN - AN ADVANTAGEOUS ADDITION IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE

      Anticancer research
    40. MEIER W; BAUMGARTNER L; STIEBER P; HASHOLZNER U; FATEHMOGHADAM A
      CA125 BASED DIAGNOSIS AND THERAPY IN RECURRENT OVARIAN-CANCER

      Anticancer research
    41. POLEY S; STIEBER P; NUSSLER V; PAHL H; FATEHMOGHADAM A
      EVALUATION OF SERUM NEURAL CELL-ADHESION MOLECULE AS A PROGNOSTIC MARKER IN MULTIPLE-MYELOMA

      Anticancer research
    42. POLEY S; STIEBER P; NUSSLER V; PAHL H; FATEHMOGHADAM A
      SERUM THYMIDINE KINASE IN NON-HODGKIN LYMPHOMAS WITH SPECIAL REGARD TO MULTIPLE-MYELOMA

      Anticancer research
    43. HASHOLZNER U; STIEBER P; MEIER W; LAMERZ R
      VALUE OF HAMA-DETERMINATION IN CLINICAL-PRACTICE - AN OVERVIEW

      Anticancer research
    44. SCHAMBECK CM; STIEBER P; SCHMELLER N; HOFMANN K; PAHL H; FATEHMOGHADAM A
      CYFRA-21-1 QUANTITY MEASUREMENT IN THE URINE OF PATIENTS WITH CARCINOMA OF THE URINARY-BLADDER AND TRACT

      Anticancer research
    45. WOLLENBERG B; JAN NV; PITZKE P; REITER W; STIEBER P
      ANTI-P53 ANTIBODIES IN SERUM OF SMOKERS AND HEAD AND NECK-CANCER PATIENTS

      Anticancer research
    46. VANDALEN A; HEERING KJ; BARAK V; PERETZ T; CREMASCHI A; GERONI P; GION M; SARACCHINI S; MOLINA R; NAMER M; STIEBER P; STURGEON C; LEONARD RCF; EINARSSON R
      TREATMENT RESPONSE IN METASTATIC BREAST-CANCER - A MULTICENTER STUDY COMPARING UICC CRITERIA AND TUMOR-MARKER CHANGES

      Breast
    47. SCHMITT UM; STIEBER P; HASHOLZNER U; PAHL H; HOFMANN K; FATEHMOGHADAM A
      METHODOLOGICAL AND CLINICAL-EVALUATION OF 2 AUTOMATED ENZYMATIC IMMUNOASSAYS AS COMPARED WITH A RADIOIMMUNOASSAY FOR NEURON-SPECIFIC ENOLASE

      European journal of clinical chemistry and clinical biochemistry
    48. STIEBER P; WOLLENBERG B; SCHMITT UM; VONJAN N; HOFMANN K; FATEHMOGHADAM A
      CLINICAL RELEVANCE OF TUMOR-MARKERS IN HE AD AND NECK SQUAMOUS-CELL CARCINOMAS

      Tumordiagnostik & Therapie
    49. HASHOLZNER U; STIEBER P; DIENEMANN H; FIEBIG M; FABRICIUS PG; MELER W; REUTER C; FATEHMOGHADAM A
      CHROMOGRANIN-A IN BENIGN AND MALIGNANT DISEASES

      Tumordiagnostik & Therapie
    50. REITER W; STIEBER P; SCHMELLER N; NAGEL D; PAHL H; MATTES M; FABRICIUS PG; FATEHMOGHADAM A
      FREE PSA - A USEFUL MARKER IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE

      Tumordiagnostik & Therapie
    51. STIEBER P; SCHMELLER N; SCHAMBECK C; HOFMANN K; REITER W; HASHOLZNER U; FATEHMOGHADAM A
      CLINICAL RELEVANCE OF CYFRA-21-1, TPA-IRMA AND TPA-LIA-MAT IN URINARY-BLADDER CANCER

      Anticancer research
    52. WOLLENBERG B; JAN V; SCHMIT UM; HOFMANN K; STIEBER P; FATEHMOGHADAM A
      CYFRA-21-1 IS NOT SUPERIOR TO SCC ANTIGEN AND CEA IN HEAD AND NECK SQUAMOUS-CELL CANCER

      Anticancer research
    53. HASHOLZNER U; BAUMGARTNER L; STIEBER P; MEIER W; REITER W; PAHL H; FATEHMOGHADAM A
      CLINICAL-SIGNIFICANCE OF THE TUMOR-MARKERS CA-125-II AND CA-72-4 IN OVARIAN-CARCINOMA

      International journal of cancer
    54. SCHMITT UM; JUNGST D; BILZER H; WACHTLER M; HEBERGER S; REITER W; WICK M; STIEBER P; SEIDEL D
      INSUFFICIENT CLINICAL RELEVANCE OF CARBOHYDRATE-DEFICIENT TRANSFERRININ THE DETECTION OF CHRONIC-ALCOHOLISM

      Gastroenterology
    55. REITER W; STIEBER P; REUTER C; NAGEL D; CRAMER C; FATEHMOGHADAM A
      SENSITIVITY AND PROGNOSTIC-SIGNIFICANCE OF CA-72-4, CEA, AND CA-19-9 SERUM LEVELS IN UNTREATED PATIENTS WITH GASTRIC-CANCER

      Tumordiagnostik & Therapie
    56. SCHAMBECK CM; SCHMELLER N; STIEBER P; JANSEN HM; PAHL H; SCHNEIDER W; FATEHMOGHADAM A
      METHODOLOGICAL AND CLINICAL COMPARISON OF THE ACS PROSTATE-SPECIFIC ANTIGEN-ASSAY AND THE TANDEM-E PROSTATE-SPECIFIC ANTIGEN-ASSAY IN PROSTATE-CANCER

      Urology
    57. VONRITTER C; EDER MI; STIEBER P; MEYER G; REUTER C; JUNGST D; LAMERZ R; PAUMGARTNER G
      BILIARY MUCIN SECRETED BY CULTURED HUMAN GALLBLADDER EPITHELIAL-CELLSCARRIES THE EPITOPE OF CA19-9

      Gastroenterology
    58. POLEY S; STIEBER P; PAHL H; FATEHMOGHADAM A
      EVALUATING A NEW BETA(2)-MICROGLOBULIN ENZYME-IMMUNOASSAY

      Tumordiagnostik & Therapie
    59. HASHOLZNER U; STIEBER P; BAUMGARTNER L; PAHL H; MEIER W; FATEHMOGHADAM A
      METHODICAL AND CLINICAL-EVALUATION OF 3 AUTOMATIZED CA 125 ASSAYS COMPARED WITH THE CA 125 II RIA

      Tumordiagnostik & Therapie
    60. HASHOLZNER U; BAUMGARTNER L; STIEBER P; MEIER W; HOFMANN K; FATEHMOGHADAM A
      SIGNIFICANCE OF THE TUMOR-MARKERS CA-125-II, CA-72-4, CASA AND CYFRA-21-1 IN OVARIAN-CARCINOMA

      Anticancer research
    61. STIEBER P; DIENEMANN H; HASHOLZNER U; MULLER C; POLEY S; HOFMANN K; FATEHMOGHADAM A
      COMPARISON OF CYTOKERATIN FRAGMENT 19 (CYFRA 21-1), TISSUE POLYPEPTIDE ANTIGEN (TPA) AND TISSUE POLYPEPTIDE SPECIFIC ANTIGEN (TPS) AS TUMOR-MARKERS IN LUNG-CANCER

      European journal of clinical chemistry and clinical biochemistry
    62. MEIER W; STIEBER P; FATEHMOGHADAM A; HEPP H
      CA-125 HALFLIFE AS NEW PROGNOSTIC FACTOR IN OVARIAN-CANCER

      Archives of gynecology and obstetrics
    63. BAUMGARTNER L; MEIER W; STIEBER P; FATEHMOGHADAM A; EIERMANN W; HEPP H
      VALUE OF TUMOR-MARKER CA-125 AS A PROGNOS TIC PARAMETER IN RECURRENT OVARIAN-CANCER

      Archives of gynecology and obstetrics
    64. ROSALKI SB; FOO AY; BURLINA A; PRELLWITZ W; STIEBER P; NEUMEIER D; KLEIN G; POPPE WA; BODENMULLER H
      MULTICENTER EVALUATION OF ISO-ALP TEST KIT FOR MEASUREMENT OF BONE ALKALINE-PHOSPHATASE ACTIVITY IN SERUM AND PLASMA

      Clinical chemistry
    65. STIEBER P; BODENMULLER H; BANAUCH D; HASHOLZNER U; DESSAUER A; OFENLOCHHAHNLE B; JAWOREK D; FATEHMOGHADAM A
      CYTOKERATIN 19 FRAGMENTS - A NEW MARKER FOR NON-SMALL-CELL LUNG-CANCER

      Clinical biochemistry
    66. STIEBER P; HASHOLZNER U; BODENMULLER H; NAGEL D; SUNDERPLASSMANN L; DIENEMANN H; MEIER W; FATEHMOGHADAM A
      CYFRA 21-1 - A NEW MARKER IN LUNG-CANCER

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 20:09:54